Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 17 March 2006. doi:10.1136/adc.2005.085449
Archives of Disease in Childhood - Fetal and Neonatal Edition 2006;91:F283-F286
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2005.085449v1
91/4/F283    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, D
Right arrow Articles by Schimmel, M S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, D
Right arrow Articles by Schimmel, M S

ORIGINAL ARTICLE

Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram

D Turner1, C Hammerman2, B Rudensky3, Y Schlesinger4, C Goia5, M S Schimmel2

1 Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel
2 Department of Neonatology, Shaare Zedek Medical Center
3 Clinical Microbiology Laboratory, Shaare Zedek Medical Center
4 Pediatric Infectious Disease Unit, Shaare Zedek Medical Center
5 Clinical Support Unit, Hospital for Sick Children, Toronto, Canada

Correspondence to:
Correspondence to:
Dr Turner
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Hospital for Sick Children, 555 University Ave, Toronto, Ont M5G-1X8, Canada; dan.turner{at}sickkids.ca

Objective: To determine normal concentrations of procalcitonin in preterm infants shortly after birth and to assess its accuracy in detecting bacterial infection.

Methods: Blood samples of 100 preterm infants were prospectively drawn during the first 4 days of life for determination of procalcitonin concentration. Infants were classified into four groups according to their sepsis status.

Results: Mean (SD) gestational age and birth weight were 32 (2.9) weeks and 1682 (500) g respectively. A total of 283 procalcitonin concentrations from healthy infants were plotted to construct nomograms of physiologically raised procalcitonin concentration after birth, stratified by two groups to 24–30 and 31–36 weeks gestation. The peak 95th centile procalcitonin concentration was plotted at 28 hours of age; values return to normal after 4 days of life. Only 12 infants were infected, and 13 of their 16 procalcitonin concentrations after birth were higher than the 95th centile, whereas samples taken at birth were lower. In a multivariable analysis, gestational age, premature rupture of membrane, and sepsis status influenced procalcitonin concentration independently, but maternal infection status did not.

Conclusions: The suggested neonatal nomograms of preterm infants are different from those of term infants. Procalcitonin concentrations exceeding the 95th centile may be helpful in detecting congenital infection, but not at birth.


Keywords: procalcitonin; preterm; congenital infection; nomogram







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health